Quality Control Test For Containers | Rubber Closures | Good Laboratory Practice | Quality Assurance
This educational video provides comprehensive coverage of pharmaceutical quality control tests for containers (glass, plastic, metal), rubber closures, and secondary packaging materials, followed by Good Laboratory Practices (GLP) for non-clinical studies.
Summary
The presentation begins with quality control testing for various pharmaceutical packaging materials. For glass containers, the instructor explains four glass types (Type 1-4) and covers essential tests including chemical resistance tests (powdered glass test and water attack test), hydrolytic resistance, light transmission, thermal shock, internal busting pressure, and leakage tests. The powdered glass test involves crushing glass containers, passing through sieves, washing with acetone, autoclaving with water, and titrating with acid to measure alkaline release.
For plastic containers, tests include leakage testing (inversion method and vacuum method), collapsibility testing for tubes, clarity of aqueous extract testing to detect particle release, transparency testing for visual clarity, and eye irritation testing using rabbits. Metal container testing involves filling 50 tubes with ointment, heating and cooling, filtering through metal filter assembly, and counting metal particles under microscope with specific scoring systems.
Rubber closure testing covers residue on evaporation, pH of aqueous extracts, sterility testing in culture media, fragmentation testing using multiple needle punctures, self-sealability testing with methylene blue dye, and penetrability testing to measure force required for needle insertion.
Secondary packaging material testing includes ten different tests: grammage (weight per unit area), thickness measurement, moisture content, folding endurance, bursting strength, water absorption, tear resistance, puncture resistance, box compression testing, and drop testing.
The second half focuses on Good Laboratory Practices (GLP), which are guidelines ensuring quality, reliability, and integrity of non-clinical laboratory studies. GLP covers organizational structure with study directors and management, qualified personnel with proper training, adequate facilities including testing areas and animal care, calibrated equipment with SOPs, and proper handling of test and control articles. The presentation explains protocols for conducting non-clinical studies, including identification codes, study objectives, personnel responsibilities, and experimental design. Record keeping and reporting requirements emphasize accurate documentation, proper storage, and comprehensive final reports. The video concludes with disqualification procedures for testing facilities that fail to comply with GLP standards and reinstatement processes.
Key Insights
- Type 1 glass (borosilicate) is the best quality glass that releases minimal alkaline content and is used for parenteral injections and sensitive drugs
- Powdered glass test requires crushing glass containers into uniform particles, washing with acetone, autoclaving with water, and titrating with acid to measure alkaline release
- Chemical resistance tests check whether glass containers react with APIs, excipients, or external gases that could compromise drug quality
- Eye irritation testing for plastic containers involves exposing rabbit eyes to plastic extracts for 24, 48, and 72 hours to check for redness or swelling
- Metal container testing uses a scoring system where particles ≥1mm score 50 points, 0.5-1mm score 10 points, and total scores must be under 100 to pass
- Fragmentation testing for rubber closures involves four repeated needle punctures and water injections to check if rubber particles are released
- Self-sealability testing uses methylene blue dye to detect if rubber closures properly seal after needle punctures without allowing dye penetration
- Good Laboratory Practices ensure quality, reliability and integrity of non-clinical studies through proper documentation, safety procedures and standard protocols
- Study directors are responsible for overall study management, protocol approval, final reports, and ensuring GLP compliance throughout non-clinical trials
- Non-clinical studies use both test articles (actual drugs) and control articles (placebos) to properly evaluate drug safety and efficacy
- Testing facilities can be disqualified for non-compliance with GLP, data manipulation, poor record keeping, inadequately trained staff, or repeated inspection failures
- Disqualified facilities can be reinstated only after rectifying all deficiencies and demonstrating full compliance with GLP standards through reinspection
Topics
Full transcript available for MurmurCast members
Sign Up to Access